High-intensity focused ultrasound for endometrial ablation in adenomyosis: a clinical study
- PMID: 38576714
- PMCID: PMC10991773
- DOI: 10.3389/fmed.2024.1332080
High-intensity focused ultrasound for endometrial ablation in adenomyosis: a clinical study
Abstract
Objective: The present study aimed to investigate the clinical efficacy of endometrial ablation with high-intensity focused ultrasound (HIFU) for symptom relief in women with adenomyosis.
Methods: Between July 2014 and July 2020, 167 patients with adenomyosis treated at the Zhongshan City People's Hospital were enrolled in this study. Patients were divided into two groups according to patient aspirations: the control group, including patients who only underwent ablation of adenomyosis lesions (group A) and the treatment group, including patients who underwent removal of adenomyosis lesions and endometrial ablation (group B).
Results: The reduced dysmenorrhea scores (visual analog scale) and menstrual volume scores (pictorial blood assessment chart) were measured before and after treatment. The scores were obtained by subtracting the postoperative scores from the preoperative scores and were compared to determine whether the symptoms had alleviated. Compared with the menstrual volume of group A, that in group B showed significant improvements. The average relief rates of dysmenorrhea in the two groups also showed significant improvement. However, the scores in group B showed a more significant improvement than those in group A.
Conclusion: Therefore, our findings suggest that endometrial ablation using HIFU may be superior to conventional therapy with regard to alleviating the symptoms of increased menstruation in women with adenomyosis.
Keywords: adenomyosis; dysmenorrhea; endometrium; high-intensity focused ultrasound; magnetic resonance imaging.
Copyright © 2024 Wu, Liu, Liu and Han.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.BJOG. 2017 Aug;124 Suppl 3:7-11. doi: 10.1111/1471-0528.14736. BJOG. 2017. PMID: 28856862
-
[Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation].Zhonghua Fu Chan Ke Za Zhi. 2016 Nov 25;51(11):845-849. doi: 10.3760/cma.j.issn.0529-567X.2016.11.009. Zhonghua Fu Chan Ke Za Zhi. 2016. PMID: 27916069 Chinese.
-
[Clinical efficacy of focused ultrasound ablation surgery in the treatment of internal adenomyosis].Zhonghua Fu Chan Ke Za Zhi. 2022 Apr 25;57(4):259-264. doi: 10.3760/cma.j.cn112141-20210915-00521. Zhonghua Fu Chan Ke Za Zhi. 2022. PMID: 35484657 Chinese.
-
Comparison of pregnancy outcomes in infertile patients with different types of adenomyosis treated with high-intensity focused ultrasound.Int J Hyperthermia. 2023;40(1):2238140. doi: 10.1080/02656736.2023.2238140. Int J Hyperthermia. 2023. PMID: 37495217 Review.
-
Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.Front Public Health. 2021 Aug 16;9:688264. doi: 10.3389/fpubh.2021.688264. eCollection 2021. Front Public Health. 2021. PMID: 34485218 Free PMC article.
Cited by
-
A Dual-Sequence MRI-Based Radiomics Model for Predicting High-Intensity Focused Ultrasound Ablation Efficacy in Adenomyosis Treatment.Int J Womens Health. 2025 May 9;17:1321-1332. doi: 10.2147/IJWH.S512216. eCollection 2025. Int J Womens Health. 2025. PMID: 40371382 Free PMC article.
References
LinkOut - more resources
Full Text Sources